Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
A Neural Organoid Model of Substance Use Disorder
EF 2021-22
Résumé
Substance Use Disorder (SUD) is defined as the persistent use of addictive substances despite substantial harm and adverse consequences. Because research into SUD is limited by the complexity of the human brain, the precise mechanisms underlying SUD remain unclear. Although many studies have been performed on neural organoid models of other neuropsychiatric diseases, SUD has yet to be investigated using neural organoids, or “mini brains,” small bundles of interconnected brain cells that are grown from human stem cells.
To create a more biologically relevant model of disease for SUD research, I aim to grow neural organoids from human pluripotent stem cells (hPSCs) and create the very first neural organoid model of Substance Use Disorder. This will involve dosing the organoids with various addictive substances and investigating how they affect the brain cells.
By introducing “reporter” genes to the mini brains, I will be able to easily visualize the cellular differences that are frequently altered in Substance Use Disorder. Additionally, I will introduce microglia (brain immune cells) to the organoids to mimic the typical immune response seen in human brains, and to probe the role of inflammation in substance abuse. To validate my SUD model, I will use various techniques to investigate drug responses, electrophysiological activities, and gene expression differences between treated and untreated organoids.
My neural organoid model of SUD will provide a fascinating new lens through which researchers can investigate substance abuse in humans. This model will be a much-needed addition to the field, allowing SUD researchers to recapitulate findings from mouse models and probe various risk factors and drug targets with greater biological relevancy than current models allow.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
480680
Name
Johns Kelly M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Neural Organoid Model of Substance Use Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Addiction; Human Pluripotent Stem Cells; Inflammation; Microglia; Model Of Addiction; Molecular Mechanisms; Neural Organoid; Neurological Disorder; Neurons; Substance Use Disorder
Abstract
Substance Use Disorder (SUD) is defined as the persistent use of addictive substances despite substantial harm and adverse consequences. Because research into SUD is limited by the complexity of the human brain, the precise mechanisms underlying SUD remain unclear. Although many studies have been performed on neural organoid models of other neuropsychiatric diseases, SUD has yet to be investigated using neural organoids, or “mini brains,” small bundles of interconnected brain cells that are grown from human stem cells.
To create a more biologically relevant model of disease for SUD research, I aim to grow neural organoids from human pluripotent stem cells (hPSCs) and create the very first neural organoid model of Substance Use Disorder. This will involve dosing the organoids with various addictive substances and investigating how they affect the brain cells.
By introducing “reporter” genes to the mini brains, I will be able to easily visualize the cellular differences that are frequently altered in Substance Use Disorder. Additionally, I will introduce microglia (brain immune cells) to the organoids to mimic the typical immune response seen in human brains, and to probe the role of inflammation in substance abuse. To validate my SUD model, I will use various techniques to investigate drug responses, electrophysiological activities, and gene expression differences between treated and untreated organoids.
My neural organoid model of SUD will provide a fascinating new lens through which researchers can investigate substance abuse in humans. This model will be a much-needed addition to the field, allowing SUD researchers to recapitulate findings from mouse models and probe various risk factors and drug targets with greater biological relevancy than current models allow.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Johns, Kelly M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~